Global Anti-Thrombin III Testing Market size is expected to reach nearly US$ 863.91 Mn by 2029 with the CAGR of 4.2% during the forecast period. The global Anti-Thrombin III Testing market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Anti-Thrombin III Testing market report also provides trends by market segments, technology, and investment with a competitive landscape.To know about the Research Methodology :- Request Free Sample Report
Global Anti-Thrombin III Testing Market Overview
Anti-thrombin is a protein found in human blood Dosage Forms that plays an important role to prevent blood clot formation by behaving as a thinner for blood. It is broadly used for people undergoing surgery with low levels of anti-thrombin in their bodies. The anti-Thrombin market was approximately at 540 US$ Mn in 2019 and is growing at a CAGR of XX% during the forecast period The deficiency of antithrombin in the body may lead to thrombosis which may lead to excessive blood loss during the surgical process. Certain tests can help in identifying antithrombin deficiency. When a person bleeds their body starts creating certain blood clots to prevent the body from losing too much blood. But sometimes the body creates an excessive amount of blood clots which are dangerous and can block the flow of blood to the vital organs. To prevent that from happening anti-thrombin plays a vital roleGlobal Anti-Thrombin III Testing Market Dynamics
The major factors responsible for the growth of the Antithrombin III testing Market include an increase in the number of surgeries performed globally, an increase in cases of extracorporeal membrane oxidation, and an increase in cases of hereditary antithrombin insufficiency in patients. Furthermore, the growing incidence of health conditions such as septic shock and the growing number of incidents of clotting disorder is expected to boost the growth. An increase in the infrastructure and key players’ investment for the development of medical procedure and techniques are driving the overall market the increase in protein deficiency among people which requires treatment and drugs in the long run. This has contributed to the production of antithrombin drugs more and increased use of rapid test have driven the antithrombin III testing market Other factor includes the advancement in technologically for the production of antithrombin testing equipment and production of drugs are propelling the market. Besides that increasing more number of drugs and medication by government and medical authorities boosting the market worldwide As per the data published by the American Society of Hematology around 900,000 people develop blood clot every year in America, which is responsible for the death of 1,00,000 people annually. However, the market is hampered by the high cost of antithrombin activities and the availability of various alternatives in the market also imposing strict regulation and protest by animal welfare institution against the testing of new drugs on animals are restraining the growth of the marketGlobal Antithrombin III Testing Market Segment Analysis
On the basis of application, the therapeutic segment was accounted for 95% in 2018. the market is also expected to witness an upsurge due to growing deficiency of proteins and excessive loss of blood during surgical procedures Antithrombin is used as a therapy in circumstances such as heart surgery and genetic disorders such as Antithrombin Deficiency. As per the data published by the American Health and Human services in 2018, it was found that 1 out of every 2000 people globally is expected to suffer from antithrombin deficiency. With this, the rise in surgical procedures and increasing incidence of liver failure, cardiac arrest due to antithrombin deficiency, and other projects is expected to drive the segment in the market during the forecast period By source, the segment of goat milk is expected to grow during the forecast period due to its clinical efficacy. The protein in goat milk is usually a short-time supply of antithrombin proteins to humans due to the availability of less blood plasma. According to the GTC Biotherapeutic, one goat is enough to generate antithrombin protein which is equal to antithrombin generated by 90,000 blood donations. An increase in the number of patients suffering from protein deficiency and an increased in investment by the market key players for the genetic generation of goat milk is anticipated to grow the market. By dosage form, the segment of lyophilized antithrombin is likely to dominate the market during the forecast period. Whereas lyophilization is defined as a process of removing liquid or water from any Application. Though it is a messy process but holds various potentials for usage and application lyophilized comes in powder form and is usually prescribed to patients to prevent post-operative and pre-partum in thromboembolic events in deficient antithrombin inpatient.Asia Pacific region accounted for US$ 179 MN in 2018 and is growing rapidly developing nations like India and China developing new treatment and healthcare procedures to fight diseases and increased income of people which in turn increasing their overall spending capabilities combined with the willingness to spend more in healthcare facilities is driving the market in the region. Increasing life expectance and demand for lower casualty rates during the surgical process existing new Applications and enhanced quality of the procedure combined with is likely to boost the market in the region during the forecast period. The European region has also witnessed growth in the market due to the use of a human-based Application for antithrombin deficiency in countries like France, Germany and the UK the launch of the new antithrombin III testing techniques by market key players will drive the market growth in the region. The continuous increase in medical demand from south Asian countries like India, China and Japan, and the Middle East Asian region will move the curve of the market upward during the forecast period North America will hold the most market share during the forecast period due to an increase in blood-related disorders and an increase in antithrombin III tastings. The region's government's high focus on providing better healthcare facilities and hospitality is expected to drive the market growth. The USA, Canada, and Mexico have recorded a continuous rise in patients with blood-related diseases. The objective of the report is to present a comprehensive analysis of the Global Antithrombin III Testing market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Antithrombin III Testing Market dynamics, structure by analyzing the market segments and project the Global Antithrombin III Testing Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Application portfolio, growth strategies, and regional presence in the Global Antithrombin III Testing Market make the report investor’s guide.
Global Antithrombin III Testing Market Regional Insights:
Global Antithrombin III Testing Market Scope: Inquire before buying
Anti-Thrombin III Testing Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $647.73,Mn. Forecast Period 2023 to 2029 CAGR: 4.2% Market Size in 2029: US $ 863.91 Mn. Segments Covered: by Application Therapeutics Research and Diagnostics Others by Dosage Form Lyophilized Liquid by Sources Humans Goat Milk Others Global Antithrombin III Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global Anti-Thrombin III Testing Market Key Players
1.Neurosoft Medical Systems Co., 2.Ltd, Bluebird Bio, Inc., 3.Emmaus Life Sciences Inc, 4.Prolong Pharmaceuticals, 5.Celgene Corporation, 6.Alnylam Pharmaceuticals, 7.Gamida Cell, 8.Acceleron Pharma, 9.Mast Therapeutic, 10.HemaQuest Pharmaceuticals, Sanofi, 11.Sangamo Therapeutics, Inc. 12.Abbot 13.Octa pharma 14.Lee biosolutions Frequently Asked Questions: 1. Which region has the largest share in Global Anti-Thrombin III Testing Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Anti-Thrombin III Testing Market? Ans: The Global Anti-Thrombin III Testing Market is growing at a CAGR of 4.2% during forecasting period 2023-2029. 3. What is scope of the Global Anti-Thrombin III Testing Market report? Ans: Global Anti-Thrombin III Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. What was the Global Anti-Thrombin III Testing Market size in 2022? Ans: The Global Anti-Thrombin III Testing market was valued at US$ 647.73 Mn. In 2022. 5. What is the study period of this Market? Ans: The Global Anti-Thrombin III Testing Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Antithrombin III Testing Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Antithrombin III Testing Applications Market 3.4. Geographical Snapshot of the Antithrombin III Testing Applications Market, By Manufacturer share 4. Global Antithrombin III Testing Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Applications 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Antithrombin III Testing Market 5. Supply Side and Demand Side Indicators 6. Global Antithrombin III Testing Market Analysis and Forecast, 2022-2029 6.1 Antithrombin III Testing Market Size & Y-o-Y Growth Analysis 7. Global Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.1.1. Therapeutics 7.1.2. Research and Diagnostics 7.1.3. Others 7.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 7.2.1. Lyophilized 7.2.2. Liquid 7.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 7.3.1. Humans 7.3.2. Goat Milk 7.3.3. Others 7.4. Market Size (Value) Estimates & Forecast by Region, 2022-2029 7.4.1. North America 7.4.2. South America 7.4.3. Europe 7.4.4. Asia Pacific 7.4.5. Middle East and Africa 8. North America Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 8.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 8.1.1. Therapeutics 8.1.2. Research & Diagnostic 8.1.3. Others 8.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 8.2.1. Lyophilized 8.2.2. Liquid 8.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 8.3.1. Humans 8.3.2. Goat Milk 8.3.3. Others 9. North America Antithrombin III Testing Market Analysis and Forecasts, By Country 9.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 9.1.1. US 9.1.2. Canada 9.1.3. Mexico 10. U.S. Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 10.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 10.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 10.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 11. Canada Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 12. Mexico Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 13. Europe Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 14. Europe Antithrombin III Testing Market Analysis and Forecasts, By Country 14.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 14.1.1. U.K 14.1.2. France 14.1.3. Germany 14.1.4. Italy 14.1.5. Spain 14.1.6. Sweden 14.1.7. CIS Countries 14.1.8. Rest of Europe 15. U.K. Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 15.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 15.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 15.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 16. France Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 17. Germany Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 18. Italy Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 19. Spain Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 20. Sweden Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 21. CIS Countries Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 22. Rest of Europe Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 23. Asia Pacific Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 24. Asia Pacific Antithrombin III Testing Market Analysis and Forecasts, by Country 24.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 24.1.1. China 24.1.2. India 24.1.3. Japan 24.1.4. South Korea 24.1.5. Australia 24.1.6. ASEAN 24.1.7. Rest of Asia Pacific 25. China Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 25.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 25.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 25.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 26. India Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 27. Japan Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 28. South Korea Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 29. Australia Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 29.4. Market Size (Value) Estimates & Forecast By Region, 2022-2029 30. ASEAN Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 31. Rest of Asia Pacific Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 32. Middle East Africa Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 33. Middle East Africa Antithrombin III Testing Market Analysis and Forecasts, by Country 33.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 33.1.1. South Africa 33.1.2. GCC Countries 33.1.3. Egypt 33.1.4. Nigeria 33.1.5. Rest of ME&A 34. South Africa Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 34.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 34.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 34.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 35. GCC Countries Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 36. Egypt Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 37. Nigeria Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 38. Rest of ME&A Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 39. South America Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 40. South America Antithrombin III Testing Market Analysis and Forecasts, by Country 40.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 40.1.1. Brazil 40.1.2. Argentina 40.1.3. Rest of South America 41. Brazil Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 41.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 41.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 41.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 42. Argentina Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 43. Rest of South America Antithrombin III Testing Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By Sources, 2022-2029 44. Competitive Landscape 44.1. Geographic Footprint of Major Players in the Global Antithrombin III Testing Market 44.2. Competition Matrix 44.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Sourcess and R&D Investment 44.2.2. New Application Launches and Application Enhancements 44.2.3. Market Consolidation 44.2.3.1. M&A by Regions, Investment and Verticals 44.2.3.2. M&A, Forward Integration and Backward Integration 44.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 44.3. Company Profile : Key Players 44.3.1. Lee biosolutions 44.3.1.1. Company Overview 44.3.1.2. Financial Overview 44.3.1.3. Geographic Footprint 44.3.1.4. Application Portfolio 44.3.1.5. Business Strategy 44.3.1.6. Recent Developments 45.3.2 Neurosoft Medical Systems Co., 45.3.3 Bluebird Bio, Inc., 45.3.4 Emmaus Life Sciences Inc, 45.3.5 Prolong Pharmaceuticals, 45.3.6 Celgene Corporation, 45.3.7 Alnylam Pharmaceuticals, 45.3.8 Gamida Cell, 45.3.9 Acceleron Pharma, 45.3.10 Mast Therapeutic, 45.3.11 HemaQuest Pharmaceuticals, Sanofi, 45.3.12 Sangamo Therapeutics, Inc. 45.3.13 Abbot 45.3.14 Octa pharma 46 Primary Key Insights